| Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: a model based analysis V Daniels, K Saxena, C Roberts, S Kothari, S Corman, L Yao, L Niccolai Vaccine 39 (20), 2731-2735, 2021 | 123 | 2021 |
| The impact of varicella vaccination on the incidence of varicella and herpes zoster in the United States: updated evidence from observational databases, 1991–2016 LJ Wolfson, VJ Daniels, A Altland, W Black, W Huang, W Ou Clinical infectious diseases 70 (6), 995-1002, 2020 | 79 | 2020 |
| Public health impact and cost-effectiveness of catch-up 9-valent HPV vaccination of individuals through age 45 years in the United States V Daniels, VS Prabhu, C Palmer, S Samant, S Kothari, C Roberts, ... Human vaccines & immunotherapeutics 17 (7), 1943-1951, 2021 | 47 | 2021 |
| Cost-effectiveness analysis of universal varicella vaccination in Turkey using a dynamic transmission model LJ Wolfson, VJ Daniels, M Pillsbury, Z Kurugöl, C Yardimci, J Kyle, ... PloS one 14 (8), e0220921, 2019 | 40 | 2019 |
| Public health impact and cost-effectiveness of a nine-valent gender-neutral HPV vaccination program in France L Majed, X Bresse, N El Mouaddin, A Schmidt, VJ Daniels, A Pavelyev, ... Vaccine 39 (2), 438-446, 2021 | 34 | 2021 |
| The cost-effectiveness of universal varicella vaccination in Italy: a model-based assessment of vaccination strategies C Azzari, V Baldo, S Giuffrida, R Gani, E O’Brien, C Alimenti, VJ Daniels, ... ClinicoEconomics and Outcomes Research, 273-283, 2020 | 29 | 2020 |
| Understanding the role of exogenous boosting in modeling varicella vaccination SE Talbird, EM La, J Mauskopf, A Altland, V Daniels, LJ Wolfson Expert Review of Vaccines 17 (11), 1021-1035, 2018 | 28 | 2018 |
| Modeling the health and economic implications of adopting a 1-dose 9-valent human papillomavirus vaccination regimen in a high-income country setting: An analysis in the United … V Daniels, K Saxena, O Patterson-Lomba, A Gomez-Lievano, A Saah, ... Vaccine 40 (14), 2173-2183, 2022 | 21 | 2022 |
| Assessing the health and economic outcomes of a 9-valent HPV vaccination program in the United Kingdom K Owusu-Edusei, C Palmer, O Ovcinnikova, G Favato, V Daniels Journal of Health Economics and Outcomes Research 9 (1), 140, 2022 | 19 | 2022 |
| Public health impact and cost effectiveness of routine childhood vaccination for hepatitis a in Jordan: a dynamic model approach WA Hayajneh, VJ Daniels, CK James, MN Kanıbir, M Pilsbury, M Marks, ... BMC Infectious Diseases 18 (1), 119, 2018 | 19 | 2018 |
| Chaotic scattering on a double well: Periodic orbits, symbolic dynamics, and scaling V Daniels, M Vallieres, JM Yuan Chaos: An Interdisciplinary Journal of Nonlinear Science 3 (4), 475-485, 1993 | 19 | 1993 |
| Structured literature review to identify human papillomavirus’s natural history parameters for dynamic population models of vaccine impacts I Diakite, B Martins, K Owusu-Edusei, C Palmer, O Patterson-Lomba, ... Infectious Diseases and Therapy 13 (5), 965-990, 2024 | 7 | 2024 |
| Budget impact analysis of multiple varicella vaccination strategies: a Mexico perspective J Graham, LJ Wolfson, J Kyle, CP Bolde-Villarreal, ... Human Vaccines & Immunotherapeutics 16 (4), 886-894, 2020 | 7 | 2020 |
| Cost-effectiveness of 9-valent HPV vaccination for patients treated for high-grade cervical intraepithelial neoplasia in the UK A Cherif, O Ovcinnikova, C Palmer, K Engelbrecht, M Reuschenbach, ... JAMA Network Open 7 (10), e2437703-e2437703, 2024 | 5 | 2024 |
| Public health impact of 2-, 4-, and 9-valent HPV vaccination in females on cervical and noncervical diseases in men and women under different coverage scenarios in China: A … I Diakite, J Kyle, S Situ, P Bai, X Zhang, W Wang, V Daniels Human Vaccines & Immunotherapeutics 19 (2), 2258569, 2023 | 5 | 2023 |
| Cost-effectiveness of routine catch-up hepatitis a vaccination in the United States: Dynamic transmission modeling study EH Elbasha, Y Choi, V Daniels, MG Goveia Vaccine 39 (42), 6315-6321, 2021 | 4 | 2021 |
| Chaotic scattering on a billiard VJ Daniels, M Vallieres, JM Yuan Physical Review E 57 (2), 1519, 1998 | 4 | 1998 |
| Modeling the health and economic implications of adopting a 1-dose 9-valent human papillomavirus vaccination program in adolescents in low/middle-income countries: An analysis … V Daniels, K Saxena, O Patterson-Lomba, A Gomez-Lievano, J At Thobari, ... PloS one 19 (11), e0310591, 2024 | 3 | 2024 |
| Cost-effectiveness of nonavalent vs bivalent HPV vaccine in Polish setting M Jakubczyk, J Bieganska, K Kowalczuk, R Jaworski, M Czech, ... Ginekologia Polska 96 (2), 119-125, 2025 | 2 | 2025 |
| Correction to: Public health impact and cost effectiveness of routine childhood vaccination for hepatitis a in Jordan: a dynamic model approach WA Hayajneh, VJ Daniels, CK James, MN Kanıbir, M Pilsbury, M Marks, ... BMC Infectious Diseases 19 (1), 904, 2019 | 2 | 2019 |
Lara J. WolfsonAVP & Head HTA StatisticsVerified email at merck.com
